Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 17, 2026 20:05 UTC |
Kemble GeorgeDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,369 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001193125-26-354018 · ownership.xml · derivative · entry 5 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,608 Underlying: Series A Common Stock · 24,369 shares Expires 2029-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F3 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:05 UTC |
Kemble GeorgeDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 326,618 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001193125-26-354018 · ownership.xml · derivative · entry 4 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,455 Underlying: Series A Common Stock · 326,618 shares Expires 2029-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F3 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:05 UTC |
Kemble GeorgeDirector
|
SaleSeries A Common Stock | 350,987 | $10.23 | $3,591,579.77 |
DisclosureSEC source: 0001193125-26-354018 · ownership.xml · nonDerivative · entry 3 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,161 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $10.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:05 UTC |
Kemble GeorgeDirector
|
Exercise / conversionSeries A Common Stock | 24,369 | $6.36 | $154,986.84 |
DisclosureSEC source: 0001193125-26-354018 · ownership.xml · nonDerivative · entry 2 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 413,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:05 UTC |
Kemble GeorgeDirector
|
Exercise / conversionSeries A Common Stock | 326,618 | $6.36 | $2,077,290.48 |
DisclosureSEC source: 0001193125-26-354018 · ownership.xml · nonDerivative · entry 1 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 388,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 23:41 UTC |
Kemble GeorgeDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,455 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001193125-26-347407 · ownership.xml · derivative · entry 5 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,977 Underlying: Series A Common Stock · 10,455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F3 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. F3 · derivative.expiration_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 23:41 UTC |
Kemble GeorgeDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,751 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001193125-26-347407 · ownership.xml · derivative · entry 4 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,073 Underlying: Series A Common Stock · 9,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F3 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. F3 · derivative.expiration_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 23:41 UTC |
Kemble GeorgeDirector
|
SaleSeries A Common Stock | 20,206 | $9.95 | $201,146.69 |
DisclosureSEC source: 0001193125-26-347407 · ownership.xml · nonDerivative · entry 3 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,161 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 23:41 UTC |
Kemble GeorgeDirector
|
Exercise / conversionSeries A Common Stock | 10,455 | $6.36 | $66,493.80 |
DisclosureSEC source: 0001193125-26-347407 · ownership.xml · nonDerivative · entry 2 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 23:41 UTC |
Kemble GeorgeDirector
|
Exercise / conversionSeries A Common Stock | 9,751 | $6.36 | $62,016.36 |
DisclosureSEC source: 0001193125-26-347407 · ownership.xml · nonDerivative · entry 1 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. Read SEC document |
| July 20, 2026 Filed Jul 22, 2026 20:05 UTC |
Happel DavidDirector · President & CEO
|
SaleSeries A Common Stock | 64,051 | $7.76 | $497,067.79 |
DisclosureSEC source: 0001193125-26-312397 · ownership.xml · nonDerivative · entry 1 Happel David · CIK 0001623567 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 741,570 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $7.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2026 Filed Jul 22, 2026 20:05 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
SaleSeries A Common Stock | 10,545 | $7.76 | $81,832.36 |
DisclosureSEC source: 0001193125-26-312394 · ownership.xml · nonDerivative · entry 1 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,414 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $7.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 20, 2026 Filed Jul 22, 2026 20:05 UTC |
Kemble GeorgeDirector
|
SaleSeries A Common Stock | 18,844 | $7.46 | $140,529.13 |
DisclosureSEC source: 0001193125-26-312386 · ownership.xml · nonDerivative · entry 1 Kemble George · CIK 0001858176 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,161 F1 · kind: These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.17 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:21 UTC |
Jarrett JenniferDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074050 · tm2617570-4_4seq1.xml · derivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:19 UTC |
Phillips Anne M.Director
|
GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074044 · tm2617570-1_4seq1.xml · derivative · entry 1 Phillips Anne M. · CIK 0001627680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:22 UTC |
Hoelscher Paul W.Director
|
GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074052 · tm2617570-5_4seq1.xml · derivative · entry 1 Hoelscher Paul W. · CIK 0001611468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:23 UTC |
SEIDENBERG BETH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074055 · tm2617570-6_4seq1.xml · derivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:20 UTC |
GRAMMER ELIZABETH ADirector
|
GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074047 · tm2617570-3_4seq1.xml · derivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 20:20 UTC |
Kemble GeorgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074045 · tm2617570-2_4seq1.xml · derivative · entry 1 Kemble George · CIK 0001858176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 28, 2026 Filed Jun 2, 2026 01:16 UTC |
Chauche ThierryChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001104659-26-069124 · tm2616578-4_4seq1.xml · derivative · entry 1 Chauche Thierry · CIK 0001895174 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Series A Common Stock · 50,000 shares Expires 2036-05-27 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 28, 2026 Filed Jun 2, 2026 01:13 UTC |
Happel DavidDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001104659-26-069121 · tm2616578-1_4seq1.xml · derivative · entry 1 Happel David · CIK 0001623567 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Series A Common Stock · 300,000 shares Expires 2036-05-27 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 28, 2026 Filed Jun 2, 2026 01:15 UTC |
Grauer AndreasChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001104659-26-069123 · tm2616578-3_4seq1.xml · derivative · entry 1 Grauer Andreas · CIK 0001770511 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Series A Common Stock · 35,000 shares Expires 2036-05-27 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 28, 2026 Filed Jun 2, 2026 01:14 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001104659-26-069122 · tm2616578-2_4seq1.xml · derivative · entry 1 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Series A Common Stock · 100,000 shares Expires 2036-05-27 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following May 28, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| April 20, 2026 Filed May 14, 2026 21:15 UTC |
Grauer AndreasChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 264,759 | $0.00 Strike: $6.44 | $0.00 |
DisclosureSEC source: 0001104659-26-061327 · tm2614553-2_4seq1.xml · derivative · entry 1 Grauer Andreas · CIK 0001770511 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,759 Underlying: Series A Common Stock · 264,759 shares Expires 2036-04-19 F1 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 20, 2027, with the remaining 75% vesting over thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:39 UTC |
Chauche ThierryChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,000 | $0.00 Strike: $5.38 | $0.00 |
DisclosureSEC source: 0001104659-26-018191 · tm266959-1_4seq1.xml · derivative · entry 2 Chauche Thierry · CIK 0001895174 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,000 Underlying: Series A Common Stock · 88,000 shares Expires 2036-02-18 F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:39 UTC |
Chauche ThierryChief Financial Officer
|
GrantSeries A Common Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-018191 · tm266959-1_4seq1.xml · nonDerivative · entry 1 Chauche Thierry · CIK 0001895174 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,688 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 16:42 UTC |
Martins Eduardo BrunoChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,000 | $0.00 Strike: $5.38 | $0.00 |
DisclosureSEC source: 0001104659-26-018194 · tm266959-3_4seq1.xml · derivative · entry 2 Martins Eduardo Bruno · CIK 0001670431 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,000 Underlying: Series A Common Stock · 88,000 shares Expires 2036-02-18 F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 16:42 UTC |
Martins Eduardo BrunoChief Medical Officer
|
GrantSeries A Common Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-018194 · tm266959-3_4seq1.xml · nonDerivative · entry 1 Martins Eduardo Bruno · CIK 0001670431 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,296 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:41 UTC |
Happel DavidDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 256,000 | $0.00 Strike: $5.38 | $0.00 |
DisclosureSEC source: 0001104659-26-018193 · tm266959-2_4seq1.xml · derivative · entry 2 Happel David · CIK 0001623567 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,000 Underlying: Series A Common Stock · 256,000 shares Expires 2036-02-18 F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:41 UTC |
Happel DavidDirector · President & CEO
|
GrantSeries A Common Stock | 128,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-018193 · tm266959-2_4seq1.xml · nonDerivative · entry 1 Happel David · CIK 0001623567 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805,621 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:43 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,000 | $0.00 Strike: $5.38 | $0.00 |
DisclosureSEC source: 0001104659-26-018196 · tm266959-4_4seq1.xml · derivative · entry 2 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,000 Underlying: Series A Common Stock · 88,000 shares Expires 2036-02-18 F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:43 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
GrantSeries A Common Stock | 44,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-018196 · tm266959-4_4seq1.xml · nonDerivative · entry 1 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,959 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:07 UTC |
Chauche ThierryChief Financial Officer
|
SaleSeries A Common Stock | 1,312 | $5.36 | $7,032.71 |
DisclosureSEC source: 0001104659-26-014277 · tm266207-3_4seq1.xml · nonDerivative · entry 1 Chauche Thierry · CIK 0001895174 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,688 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:06 UTC |
Martins Eduardo BrunoChief Medical Officer
|
SaleSeries A Common Stock | 3,640 | $5.36 | $19,511.13 |
DisclosureSEC source: 0001104659-26-014272 · tm266207-2_4seq1.xml · nonDerivative · entry 1 Martins Eduardo Bruno · CIK 0001670431 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,296 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC |
Happel DavidDirector · President & CEO
|
SaleSeries A Common Stock | 12,101 | $5.36 | $64,864.99 |
DisclosureSEC source: 0001104659-26-014283 · tm266207-4_4seq1.xml · nonDerivative · entry 1 Happel David · CIK 0001623567 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 677,621 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:05 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
SaleSeries A Common Stock | 2,622 | $5.36 | $14,054.44 |
DisclosureSEC source: 0001104659-26-014266 · tm266207-1_4seq1.xml · nonDerivative · entry 1 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,959 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 23:13 UTC |
Kemble GeorgeDirector · Executive Chairman
|
SaleSeries A Common Stock | 37,688 | $7.69 | $289,979.01 |
DisclosureSEC source: 0001104659-25-115071 · tm2531988-1_4seq1.xml · nonDerivative · entry 1 Kemble George · CIK 0001858176 · Director · Executive Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,005 F1 · kind: These sales were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.27 to $8.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:43 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,367 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001104659-25-107806 · tm2530509-1_4seq1.xml · derivative · entry 2 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,367 Underlying: Series A Common Stock · 13,367 shares Expires 2035-11-03 F2 · derivative.exercise_date: This option was granted in connection with the Reporting Person's promotion within the Company. The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:43 UTC |
Rozek ElizabethChief Legal & Admin. Officer
|
GrantSeries A Common Stock | 9,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-107806 · tm2530509-1_4seq1.xml · nonDerivative · entry 1 Rozek Elizabeth · CIK 0001975022 · Chief Legal & Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,581 F1 · shares: Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's promotion within the Company. Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 16:15 UTC |
Martins Eduardo BrunoChief Medical Officer
|
SaleSeries A Common Stock | 8,277 | $9.13 | $75,607.08 |
DisclosureSEC source: 0001104659-25-070015 · tm2521574-2_4seq1.xml · nonDerivative · entry 1 Martins Eduardo Bruno · CIK 0001670431 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,936 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:16 UTC |
Happel DavidDirector · President & CEO
|
SaleSeries A Common Stock | 65,478 | $9.13 | $598,115.34 |
DisclosureSEC source: 0001104659-25-070017 · tm2521574-3_4seq1.xml · nonDerivative · entry 1 Happel David · CIK 0001623567 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 689,722 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:14 UTC |
Rozek ElizabethGeneral Counsel and CCO
|
SaleSeries A Common Stock | 10,780 | $9.13 | $98,470.99 |
DisclosureSEC source: 0001104659-25-070013 · tm2521574-1_4seq1.xml · nonDerivative · entry 1 Rozek Elizabeth · CIK 0001975022 · General Counsel and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,726 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:38 UTC |
Jarrett JenniferDirector
|
GrantStock Option (Right to Buy) · Derivative | 27,268 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058222 · tm2517621-3_4seq1.xml · derivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,268 Underlying: Series A Common Stock · 27,268 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:41 UTC |
Phillips Anne M.Director
|
GrantStock Option (Right to Buy) · Derivative | 27,268 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058224 · tm2517621-5_4seq1.xml · derivative · entry 1 Phillips Anne M. · CIK 0001627680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,268 Underlying: Series A Common Stock · 27,268 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:37 UTC |
Hoelscher Paul W.Director
|
GrantStock Option (Right to Buy) · Derivative | 32,250 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058221 · tm2517621-2_4seq1.xml · derivative · entry 1 Hoelscher Paul W. · CIK 0001611468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,250 Underlying: Series A Common Stock · 32,250 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:42 UTC |
SEIDENBERG BETH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,250 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058225 · tm2517621-6_4seq1.xml · derivative · entry 2 SEIDENBERG BETH C · CIK 0001184592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,250 Underlying: Series A Common Stock · 32,250 shares Expires 2035-06-08 F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:36 UTC |
GRAMMER ELIZABETH ADirector
|
GrantStock Option (Right to Buy) · Derivative | 32,250 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058220 · tm2517621-1_4seq1.xml · derivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,250 Underlying: Series A Common Stock · 32,250 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:43 UTC |
Walbert Timothy PDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,250 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058226 · tm2517621-7_4seq1.xml · derivative · entry 1 Walbert Timothy P · CIK 0001349376 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,250 Underlying: Series A Common Stock · 32,250 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:40 UTC |
Kemble GeorgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 32,250 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058223 · tm2517621-4_4seq1.xml · derivative · entry 1 Kemble George · CIK 0001858176 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,250 Underlying: Series A Common Stock · 32,250 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 21:42 UTC |
SEIDENBERG BETH CDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,522 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001104659-25-058225 · tm2517621-6_4seq1.xml · derivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,522 Underlying: Series A Common Stock · 28,522 shares Expires 2035-06-05 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 6, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.